Physician profile
Dean Stokes
NPI 1639173370
$534.93
in general payments reported to CMS, 2019-2025
12 companies · $125 in 2025
The $125 reported for 2025 was less than what a typical Dermatology provider received nationally (typical 2025 total: $772).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $108 · 2020: $63.74 · 2021: $33.87 · 2022: $61.16 · 2023: $37.46 · 2024: $106 · 2025: $125.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $268.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $267.86 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $164.62 | 2019-2025 | Skyrizi |
| Sun Pharmaceutical Industries INC. | $101.81 | 2019-2025 | |
| Smith+Nephew, INC. | $73.86 | 2024-2025 | Stravix Pl, Renasys Touch |
| Chiesi USA, INC. | $36.26 | 2024 | Filsuvez |
| Genentech USA, INC. | $31.41 | 2025 | Xolair |
| Lilly USA, LLC | $26.26 | 2019 | |
| Biocomposites INC | $22.42 | 2025 | Stimulan |
| Novartis Pharmaceuticals Corporation | $22.01 | 2020 | |
| Merz North America, INC. | $16.33 | 2019 | |
| Mimedx Group, INC. | $15.64 | 2024 | |
| Advanced Oxygen Therapy INC. | $12.30 | 2024 | Topical Oxygen Chamber For Extremities |
| Pfizer INC. | $12.01 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Dean Stokes listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.